Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shengxuebao mixture for tumor-related anemia
ChiCTR2200061129Phase 4Not yet recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Sep 2021
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in anaemia comparing Shengxuebao mixture with Placebo (2 arms). Primary endpoints: Hemoglobin improvement rate at week 4 and Improvement rate of TCM syndromes at week 4. Planned start Sep 2021; status: not yet recruiting.
02
Drugs
Shengxuebao Heji
03
Conditions
anaemia
Beyond the preview
Go deeper on ChiCTR2200061129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061129.